Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 8-K call announcement, 10-Q stay in one workspace.
INBX
$95.30
+6.14%
INBX
· Inhibrx Biosciences, Inc.
$95.30
+5.51 (+6.14%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.32B
Shares
14.72M
Volume · Oct 20
221.46K
Avg daily vol (3M)
274.07K
All webcasts
Earnings call · FY2026 Q1
Inhibrx Biosciences, Inc. (INBX) Q1 2026 Earnings Call
Diluted EPS
-$2.15
Net income
-$33.44M
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 19, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 14, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Apr 21, 2026 · complete as-filed document